RETROVIR

This brand name is authorized in Austria, Australia, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug RETROVIR contains one active pharmaceutical ingredient (API):

1 Zidovudine
UNII 4B9XT59T7S - ZIDOVUDINE

Zidovudine is an antiviral agent which is highly active in vitro against retroviruses including the Human Immunodeficiency Virus (HIV).

Read about Zidovudine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
RETROVIR Capsules, hard Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
RETROVIR Concentrate for solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
RETROVIR Oral solution/syrup Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J05AF01 Zidovudine J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Discover more medicines within J05AF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10266H, 10360G, 10361H
Country: CA Health Products and Food Branch Identifier(s): 01902644, 01902652, 01902660
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 26.014-10-04
Country: EE Ravimiamet Identifier(s): 1113422, 1664670
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 57486
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 115591
Country: FR Base de données publique des médicaments Identifier(s): 60132743, 60524598, 63894243, 69290545
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 379090, 43938, 43941, 43944, 46203
Country: HK Department of Health Drug Office Identifier(s): 42757, 59602
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 3108, 3543, 4298, 8648
Country: JP 医薬品医療機器総合機構 Identifier(s): 6250001M1038
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1090662, 1090663
Country: MT Medicines Authority Identifier(s): MA1297/00101, PI565/07804A
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 142M91, 248M91
Country: NL Z-Index G-Standaard Identifier(s): 13619519, 14009919
Country: NL Z-Index G-Standaard, PRK Identifier(s): 24724, 33499, 36943
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 5021, 5022, 5023
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100081337, 100081343, 100198097, 100198499
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65176002, W65176003, W65176004, W65177001, W65177002
Country: SG Health Sciences Authority Identifier(s): 07527P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 23013011H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699522152285, 8699522572687, 8699522772605
Country: US FDA, National Drug Code Identifier(s): 49702-211, 49702-212, 49702-213
Country: ZA Health Products Regulatory Authority Identifier(s): 29/20.2.8/0483

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.